How to Travel with Semaglutide
US$ 25.15
gip/glp-1 GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Dual GLP-1/GIP Agonist | Tirzepatide
Description
It's crucial to know if these meds are right for *your* health journey.
March 25, 2024
Effectiveness and Impact Significant Weight Loss: Phase 2 studies showed up to roughly 20% average body weight loss at 52 weeks in participants with obesity
Ghrelin generated a hyperpolarising current and GLP-1 generated a depolarising current in isolated NG neurons in a patch-clamp experiment
There is currently no strong evidence that GLP-1 receptor agonists directly cause thrombosis or blood clots
